NCT02086188View on ClinicalTrials.gov

Study of Behavioral Modification Program and Mirabegron to Improve Urinary Urgency in Multiple Sclerosis

PHASE4CompletedINTERVENTIONAL

Enrollment

28

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

April 30, 2019

Study Completion Date

June 30, 2019

Conditions

Multiple Sclerosis

Interventions

DRUG

Mirabegron

see detailed information in associated Arm Description

DRUG

Placebo

Sugar pill manufactured to mimic Mirabegron 25mg tablet.

Trial Locations (1)

98034

EvergreenHealth MS Center, Kirkland

Sponsors

Collaborators (1)

Astellas Pharma Inc

All Listed Sponsors

collaborator

Astellas Pharma Inc

INDUSTRY

lead

Theodore R. Brown, MD MPH

OTHER